05.26.26 -- Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease

Learn about the development of a serum-free suspension MDCK cell line that serves as an optimal platform for isolating human influenza viruses from clinical samples and producing vaccines at scale.

Efficient DNA and RNA purification is vital as sequencing workflows scale. Explore how a multi-well format ensures reliable binding across plasmid, genomic, and total RNA applications.

Retinal gene therapies offer vital new pathways for treating wet AMD. Examine the key clinical, regulatory, and operational strategies required to move these complex therapeutics forward.

Review a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

Analyze two distinct case studies demonstrating how developers successfully overcome obstacles while navigating workflows using master virus seed stocks and working virus bank manufacturing.

Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.

Evaluate methods for optimizing iPSC culture conditions. This systematic framework drives significant increases in total cell numbers while fully preserving critical stem cell features.

Address the rising gene therapy demands with an innovative perfusion strategy that significantly boosts cell density and viral vector yields to pave the way for scalable, efficient manufacturing.

Discover an innovative TCT-LS process for CAR-T cell therapy that targets blood cancers, solid tumors, and infectious diseases, as well as learn about its unique features, limitations, and how it enhances strategies.

Master the essential strategies for cost-effective and robust mRNA capping at industrial scale. Learn how to successfully evaluate new materials and optimize your synthesis process for maximum efficiency and yield.